Brimonidine Tartrate Solution
Product Images NDC 61314-143

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 61314-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical (Image 01)

Chemical structure diagram of Brimonidine Tartrate showing its molecular components and bonds. The image also includes the chemical formula C11H10BrN5 · C4H6O6 and the CAS number 59803-98-4.*

FDA Label Image

5ml-switzerland-coo-carton (Switzerlandcarton)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2%, 5 mL sterile solution, labeled by Sandoz Inc. The label includes dosage form and strength, manufacturer information, storage instructions, active and inactive ingredients, and usual dosage directions for ophthalmic use.*

FDA Label Image

5ml-usa-coo-carton (Usacarton)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2%, sterile 5 mL, for topical ophthalmic use only. The label includes the product name, strength, quantity, manufacturer details (Alcon Laboratories Inc. and Sandoz Inc.), barcode, and storage instructions. The label also lists active and inactive ingredients and dosage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.